(Q42446341)

31 October 2017

Interferon-stimulated gene expression and hepatitis C viral dynamics during different interferon regimens (English)

1 reference

31 October 2017

2

Namiki Izumi

1 reference

31 October 2017

Yasuhiro Asahina

1

1 reference

31 October 2017

Masakatsu Uchihara

3

1 reference

31 October 2017

Osamu Noguchi

4

1 reference

31 October 2017

Yuki Nishimura

5

1 reference

31 October 2017

Kazunari Inoue

6

1 reference

31 October 2017

Ken Ueda

7

1 reference

31 October 2017

Kaoru Tsuchiya

8

1 reference

31 October 2017

Kosei Hamano

9

1 reference

31 October 2017

Jun Itakura

10

1 reference

31 October 2017

Shozo Miyake

11

1 reference

31 October 2017

1 September 2003

1 reference

31 October 2017

Journal of Hepatology

1 reference

31 October 2017

39

1 reference

31 October 2017

3

1 reference

31 October 2017

421-427

1 reference

The emerging role of the interferon-induced PKR protein kinase as an apoptotic effector: a new face of death?

31 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Intrahepatic mRNA expression of interferon-inducible antiviral genes in liver diseases: dsRNA-dependent protein kinase overexpression and RNase L inhibitor suppression in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Enhanced virus resistance of transgenic mice expressing the human MxA protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Dynamics of hepatitis C viremia following interferon-alpha administration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Resolution of acute hepatitis C after therapy with natural beta interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Different turnover rate of hepatitis C virus clearance by different treatment regimen using interferon-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Rapid decrease of plasma HCV RNA in early phase of twice daily administration of 3 MU doses interferon-beta in patients with genotype 1b hepatitis C infection: a multicenter randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Real-time detection system for quantification of hepatitis C virus genome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Peginterferon alfa-2a in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

Hepatitis C virus-RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: evidence for viral replication in peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900287-3

7 January 2021

10.1016/S0168-8278(03)00287-3

Identifiers

DOI

1 reference

31 October 2017

1 reference